New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
18:56 EDTENH, AHLAspen Insurance holders overwhelmingly reject Endurance authorization proposals
Aspen Insurance Holdings (AHL) announced that, based on preliminary voting results as of the close of business on July 25, the target date for receiving consents set by Endurance Specialty Holdings (ENH), the overwhelming majority of Aspen shareholders participating in the consent solicitation have rejected both of Enduranceís proposals. Based on these preliminary results, as provided by the companyís proxy solicitor, Aspen believes that shareholders owning at least 76% of Aspenís outstanding shares did not support Enduranceís proposal to call a special meeting at which shareholders would vote on a proposal to increase the size of Aspenís Board to 19 directors, and shareholders holding at least 81% of Aspenís outstanding shares did not support Endurance petitioning the Supreme Court of Bermuda as part of a legal maneuver called an involuntary scheme of arrangement. Of these amounts, shareholders holding more than 60% of Aspenís outstanding shares took action to affirmatively reject both proposals on Aspenís blue revocation card. Thus, Aspen estimates that the number of shares affirmatively rejecting both Endurance proposals was at least two-and-a-half times as many as the number that consented.
News For AHL;ENH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
16:30 EDTAHLAspen Insurance reports Q2 EPS 99c, consensus $1.38
Subscribe for More Information
July 20, 2015
10:00 EDTAHLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:19 EDTAHLAspen Insurance upgraded to Neutral from Underperform at Macquarie
Macquarie upgraded Aspen Insurance to Neutral and increased its price target to $49 from $40 citing fair valuation and industry consolidation.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use